| First Author | Tamura A | Year | 2022 |
| Journal | Biochem Biophys Res Commun | Volume | 628 |
| Pages | 147-154 | PubMed ID | 36087511 |
| Mgi Jnum | J:333468 | Mgi Id | MGI:7343322 |
| Doi | 10.1016/j.bbrc.2022.08.046 | Citation | Tamura A, et al. (2022) Zranb1-mutant mice display abnormal colonic mucus production and exacerbation of DSS-induced colitis. Biochem Biophys Res Commun 628:147-154 |
| abstractText | Expression of mucin MUC2, a component of the colonic mucus layer, plays a crucial role in intestinal homeostasis. Here, we describe a new regulator of MUC2 expression, the deubiquitinase ZRANB1 (Trabid). A ZRANB1 mutation changing cysteine to serine in amino acid position 443, affects ubiquitination. To analyze ZRANB1 function in the intestine, we generated Zranb1 C443S mutant knock-in (Zranb1(C443S/C443S)) mice using the CRISPR/Cas9 system. Zranb1(C443S/C443S) mice exhibited decreased mRNA expression and MUC2 production. Colonic organoids from Zranb1(C443S/C443S) mice displayed decreased Muc2 mRNA expression following differentiation into goblet cells. Finally, we analyzed dextran sulfate sodium-induced colitis to understand ZRANB1's role in intestinal inflammation. Zranb1(C443S/C443S) mice with colitis exhibited significant weight loss, reduced colon length, and worsening clinical and pathological scores, indicating that ZRANB1 contributes to intestinal homeostasis. Together, these results suggest that ZRANB1 regulates MUC2 expression and intestinal inflammation, which may help elucidating the pathogenesis of inflammatory bowel disease and developing new therapeutics targeting ZRANB1. |
